FDA issues Emergency Use Authorization for third COVID-19 vaccine
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
More News: Coronavirus | COVID-19 | Emergency Medicine | Food and Drug Administration (FDA) | Pharmaceuticals | Respiratory Medicine | SARS | Vaccines